MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

Kodu・Aktsiate loetelu・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Suletud

SektorTervishoid

35.92 -0.69

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

34.95

Max

36.9

Põhinäitajad
By Trading Economics
Sissetulek	11M 51M
Müük	39M 239M
P/E Sektori keskmine	12.073 90.831
Aktsiakasum	1.08
Kasumimarginaal	21.242
Töötajad	268
EBITDA	14M 73M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+20.79% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	24. veebr 2026

Turustatistika
By TradingEconomics
Turukapital	517M 2.2B
Eelmine avamishind	36.61
Eelmine sulgemishind	35.92

Uudiste sentiment

By Acuity

58%

42%

310 / 361 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

29.8 / N/A Toetus ja vastupanu

Harmony Biosciences Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

19. jaan 2026, 16:17 UTC

Omandamised, ülevõtmised, äriostud

Zurich Insurance Makes $10 Billion Bid for U.K. Specialist Insurer Beazley -- Update

19. jaan 2026, 23:50 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over U.S.-Europe Relations -- Market Talk

19. jaan 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Likely Technical Correction -- Market Talk

19. jaan 2026, 22:29 UTC

Market Talk

China Infant Formula Market May Hold Up Despite Steep Drop in Births -- Market Talk

19. jaan 2026, 22:29 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

19. jaan 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

19. jaan 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

19. jaan 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

19. jaan 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

19. jaan 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

19. jaan 2026, 17:09 UTC

Market Talk

Global Equities Roundup: Market Talk

19. jaan 2026, 17:09 UTC

Market Talk

Copper Rises in Spite of Softer Dollar, Trade Concerns -- Market Talk

19. jaan 2026, 16:18 UTC

Market Talk

New Zealand Dollar Could Recover Against Swedish Krona -- Market Talk

19. jaan 2026, 16:12 UTC

Market Talk

Norwegian Krone's Recent Gains Are Unlikely to Last -- Market Talk

19. jaan 2026, 16:06 UTC

Omandamised, ülevõtmised, äriostud

LVMH: Deal Completion Subject to Customary Closing Conditions and Expected to Close in Around Two Months

19. jaan 2026, 16:04 UTC

Omandamised, ülevõtmised, äriostud

LVMH: Both Parties Aim to Set Up Strategic Cooperation in the Retail Sector

19. jaan 2026, 16:03 UTC

Omandamised, ülevõtmised, äriostud

LVMH, CTG Duty-Free Also Entered Into a MoU

19. jaan 2026, 16:02 UTC

Omandamised, ülevõtmised, äriostud

LVMH: Subscription to Be Made Upon Completion of Transaction

19. jaan 2026, 16:00 UTC

Omandamised, ülevõtmised, äriostud

LVMH: Capital Increase by Subscribing to Newly Issued H-shares Listed in Hong Kong

19. jaan 2026, 16:00 UTC

Market Talk

Term Premium on U.S. Treasurys Looks Too Low, Says Pictet AM -- Market Talk

19. jaan 2026, 15:58 UTC

Omandamised, ülevõtmised, äriostud

LVMH and the Miller Family Will Participate in a Capital Increase of CTG DutyFree

19. jaan 2026, 15:57 UTC

Omandamised, ülevõtmised, äriostud

LVMH: DFS Will Continue to Operate Its Other Luxury Travel Retail Operations Worldwide

19. jaan 2026, 15:57 UTC

Omandamised, ülevõtmised, äriostud

LVMH: Proceeds of Transaction Will Be Paid in Cash

19. jaan 2026, 15:56 UTC

Omandamised, ülevõtmised, äriostud

LVMH: CTG Duty-Free Will Run the Acquisition Through Its Subsidiary China Duty Free International Limited

19. jaan 2026, 15:53 UTC

Omandamised, ülevõtmised, äriostud

LVMH: Intangible Assets Include a Series of DFS Brands and IP for Exclusive Use in Greater China

19. jaan 2026, 15:52 UTC

Omandamised, ülevõtmised, äriostud

LVMH: CTG Duty-Free to Acquire the DFS Retail Stores in Hong Kong and Macau and Intangible Assets

19. jaan 2026, 15:51 UTC

Omandamised, ülevõtmised, äriostud

LVMH: DFS, CTG Duty-Free Reach Definitive Pact for CTG Duty-Free to Buy DFS' Travel Retail Unit in Hong Kong and Macau and Intangible Assets in Greater China

19. jaan 2026, 15:39 UTC

Market Talk

Canadian Dollar's Underperformance Looks Overstretched -- Market Talk

19. jaan 2026, 15:37 UTC

Market Talk

Bank of Canada Could Consider Cutting Rates if Underlying Inflation Slows Further -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Harmony Biosciences Holdings Inc Prognoos

Hinnasiht

By TipRanks

20.79% tõus

12 kuu keskmine prognoos

Keskmine 43.75 USD 20.79%

Kõrge 55 USD

Madal 32 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Harmony Biosciences Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

5 ratings

Osta

Hoia

Müü

Põhineb 5 analüütiku instrumendi Harmony Biosciences Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

29.8 / N/AToetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

310 / 361 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.